1. Home
  2. CMPS vs MEI Comparison

CMPS vs MEI Comparison

Compare CMPS & MEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPS
  • MEI
  • Stock Information
  • Founded
  • CMPS 2020
  • MEI 1946
  • Country
  • CMPS United Kingdom
  • MEI United States
  • Employees
  • CMPS N/A
  • MEI N/A
  • Industry
  • CMPS Biotechnology: Pharmaceutical Preparations
  • MEI Electrical Products
  • Sector
  • CMPS Health Care
  • MEI Technology
  • Exchange
  • CMPS Nasdaq
  • MEI Nasdaq
  • Market Cap
  • CMPS 362.6M
  • MEI 402.1M
  • IPO Year
  • CMPS 2020
  • MEI N/A
  • Fundamental
  • Price
  • CMPS $5.04
  • MEI $9.31
  • Analyst Decision
  • CMPS Strong Buy
  • MEI Hold
  • Analyst Count
  • CMPS 7
  • MEI 3
  • Target Price
  • CMPS $30.67
  • MEI $12.50
  • AVG Volume (30 Days)
  • CMPS 1.5M
  • MEI 354.2K
  • Earning Date
  • CMPS 10-31-2024
  • MEI 12-05-2024
  • Dividend Yield
  • CMPS N/A
  • MEI 6.02%
  • EPS Growth
  • CMPS N/A
  • MEI N/A
  • EPS
  • CMPS N/A
  • MEI N/A
  • Revenue
  • CMPS N/A
  • MEI $1,083,300,000.00
  • Revenue This Year
  • CMPS N/A
  • MEI N/A
  • Revenue Next Year
  • CMPS N/A
  • MEI $5.73
  • P/E Ratio
  • CMPS N/A
  • MEI N/A
  • Revenue Growth
  • CMPS N/A
  • MEI N/A
  • 52 Week Low
  • CMPS $4.05
  • MEI $8.54
  • 52 Week High
  • CMPS $12.75
  • MEI $25.34
  • Technical
  • Relative Strength Index (RSI)
  • CMPS 39.50
  • MEI 41.24
  • Support Level
  • CMPS $4.79
  • MEI $8.70
  • Resistance Level
  • CMPS $5.57
  • MEI $9.35
  • Average True Range (ATR)
  • CMPS 0.47
  • MEI 0.40
  • MACD
  • CMPS -0.00
  • MEI 0.04
  • Stochastic Oscillator
  • CMPS 40.74
  • MEI 37.20

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About MEI Methode Electronics Inc.

Methode Electronics Inc makes component and subsystem devices employing electrical, radio remote control, electronic, wireless, and sensing technologies. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles. The products manufactured in the automotive segment include overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors. Geographically, the company generates maximum revenue from North America and the rest from Europe, the Middle East & Africa (EMEA), and Asia.

Share on Social Networks: